Controlled inhalation improves central and peripheral deposition in cystic fibrosis patients with moderate lung disease
Journal of Paediatrics and Child Health2022Vol. 58(6), pp. 1066–1068
Citations Over Time
Abstract
These pilot data suggest that this approach may prove to be clinically relevant in improving the efficacy of inhaled medication in those with moderate-severe lung disease.
Related Papers
- → Early Detection of Lung Disease in Children with Cystic Fibrosis Using Lung Function(2008)27 cited
- → Interpretation of lung function in infants and young children with cystic fibrosis(2014)23 cited
- → Early Detection of Lung Disease and Its Association with the Nutritional Status, Genetic Background and Life Events in Patients with Cystic Fibrosis(2000)25 cited
- Hfe 282Y Mutations Are Associated with Severity of Lung Disease and Rate of Lung Function Decline in Cystic Fibrosis(2014)
- → P354 West Midlands Adult Cystic Fibrosis Centre experience of the effects of Kaftrio® on patients within the lung transplant programme(2023)